You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysisImpact of B-cell malignancy therapy on COVID-19 outcomes
|
|---|---|
| Published in |
Blood Cancer Discovery, March 2022
|
| DOI | 10.1158/2643-3230.bcd-22-0013 |
| Pubmed ID | |
| Authors |
Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A Mesa, Sanjay Mishra, Daniel P Mundt, Dimpy P Shah, R Alejandro Sica, Keith E Stockerl-Goldstein, Catherine Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa Accordino, Sarit E Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Mehmet Asim Bilen, Cecilia A Castellano, Jacob C Cogan, Devendra Kc, Christopher R Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A Johnson, Monika Joshi, Anup Kasi, Elizabeth J Klein, Vadim S Koshkin, Nicole M Kuderer, Daniel H Kwon, Chris Labaki, Tahir Latif, Eric Lau, Xuanyi Li, Gary H Lyman, Rana R McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K Nonato, Adam J Olszewski, Hyma V Polimera, Andrew J Portuguese, Matthew M Puc, Pedram Razavi, Rachel Rosovski, Andrew Schmidt, Sumit A Shah, Aditi Shastri, Christopher Su, Pallawi Torka, Trisha M Wise-Draper, Leyre Zubiri, Jeremy L Warner, Michael A Thompson |
X Demographics
The data shown below were collected from the profiles of 70 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 34 | 49% |
| Australia | 2 | 3% |
| Canada | 2 | 3% |
| Spain | 2 | 3% |
| Uruguay | 1 | 1% |
| Turkey | 1 | 1% |
| India | 1 | 1% |
| United Kingdom | 1 | 1% |
| Comoros | 1 | 1% |
| Other | 0 | 0% |
| Unknown | 25 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 35 | 50% |
| Scientists | 23 | 33% |
| Practitioners (doctors, other healthcare professionals) | 9 | 13% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 2 | 20% |
| Student > Ph. D. Student | 1 | 10% |
| Professor | 1 | 10% |
| Student > Master | 1 | 10% |
| Student > Postgraduate | 1 | 10% |
| Other | 0 | 0% |
| Unknown | 4 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Environmental Science | 1 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 10% |
| Nursing and Health Professions | 1 | 10% |
| Immunology and Microbiology | 1 | 10% |
| Medicine and Dentistry | 1 | 10% |
| Other | 1 | 10% |
| Unknown | 4 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2024.
All research outputs
#901,456
of 25,270,999 outputs
Outputs from Blood Cancer Discovery
#41
of 204 outputs
Outputs of similar age
#22,375
of 435,805 outputs
Outputs of similar age from Blood Cancer Discovery
#5
of 18 outputs
Altmetric has tracked 25,270,999 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 204 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,805 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.